Centerbridge Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History
Bought
Maintained
Sold
Other funds holding SHAC
AC
GCL
Centerbridge Partners's SHAC Position: Q1 2022 in Review
Centerbridge Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q1 2022, closing a stake of 100,000 shares — an estimated $980K sold.
Centerbridge Partners first reported a position in SHAC in Q1 2021 and held it in 4 quarters. The position peaked at $980K in Q4 2021. 68 funds tracked by Wall St. Rank hold SHAC as of Q1 2022.
- Centerbridge Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- Centerbridge Partners sold 100,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q1 2022, an estimated $980K.
- Centerbridge Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 4 quarters.
- Centerbridge Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $980K in Q4 2021.
- 68 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q1 2022.
Based on Centerbridge Partners's 13F filing for Q1 2022, filed 16 May 2022.